Richard Hatchett & Moderna
3 shared events · Importance 3 · Last updated Jun 11, 2026
Live sentiment trends, interaction importance charts, and action volume tracking available on the
NewsDesk Dashboard
Tech
Richard Hatchett: Dr. Richard Hatchett>>>, CEO of Coalition for Epidemic Preparedness Innovations>>>, emphasized the urgency of funding to advance safe and effective vaccines against the Bundibugyo virus.
Moderna: Moderna received up to $50 million from CEPI to support the preclinical and early clinical development of its mRNA-based Ebola Bundibugyo vaccine candidate, leveraging its mRNA platform for rapid response.
May 22, 2026 · 36 articles
International
Richard Hatchett: Dr. Richard Hatchett, CEO of CEPI, emphasizes the urgency of developing licensed vaccines for the rapidly spreading Bundibugyo virus, stating that 'every day counts'.
Moderna: Moderna is utilizing its mRNA technology to develop a vaccine for the Bundibugyo strain of Ebola, with funding from CEPI, aiming to rapidly train the body to fight the virus.
May 21, 2026 · 627 articles
Accidents
Richard Hatchett: Richard Hatchett>>>, head of the Coalition for Epidemic Preparedness Innovations>>>, expressed high concern about the outbreak's control challenges.
Moderna: Moderna is one of the entities developing an experimental vaccine for the Bundibugyo virus, which could lead to future revenue and enhance its reputation in vaccine development.
May 18, 2026 · 505 articles
NEWSDESK
Explore this relationship live
Track how Richard Hatchett and Moderna interact across events, view sentiment trends, and discover connected entities.
Open Dashboard